Cell and Gene Therapy
Work with our experts to ensure safe and compliant research conduct for your cell and gene therapy studies.
- IBC review
- Site training
- Site assessments
- Phase-appropriate regulatory strategy
- Risk evaluation and mitigation strategies
- Quality management systems
- Independent asset reviews
- Safety monitoring
- HEO research
- And more
DATE
Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour